287 related articles for article (PubMed ID: 16188972)
21. Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process.
Kuo CW; Mirsaliotis A; Brighty DW
J Immunol; 2011 Jul; 187(1):361-71. PubMed ID: 21646298
[TBL] [Abstract][Full Text] [Related]
22. Interaction between the HTLV-1 envelope and cellular proteins: impact on virus infection and restriction.
Ilinskaya A; Heidecker G; Jones K
Future Med Chem; 2010 Nov; 2(11):1651-68. PubMed ID: 21428837
[TBL] [Abstract][Full Text] [Related]
23. CRM1, an RNA transporter, is a major species-specific restriction factor of human T cell leukemia virus type 1 (HTLV-1) in rat cells.
Zhang X; Hakata Y; Tanaka Y; Shida H
Microbes Infect; 2006 Mar; 8(3):851-9. PubMed ID: 16504563
[TBL] [Abstract][Full Text] [Related]
24. Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.
Xie L; Green PL
J Virol; 2005 Dec; 79(23):14536-45. PubMed ID: 16282453
[TBL] [Abstract][Full Text] [Related]
25. Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication.
de Parseval A; Ngo S; Sun P; Elder JH
J Virol; 2004 Sep; 78(17):9132-43. PubMed ID: 15308709
[TBL] [Abstract][Full Text] [Related]
26. Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase.
Ruggero K; Guffanti A; Corradin A; Sharma VK; De Bellis G; Corti G; Grassi A; Zanovello P; Bronte V; Ciminale V; D'Agostino DM
J Virol; 2014 Apr; 88(7):3612-22. PubMed ID: 24403582
[TBL] [Abstract][Full Text] [Related]
27. In vitro cellular tropism of human T cell leukemia virus type 2.
Wang TG; Ye J; Lairmore MD; Green PL
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1661-8. PubMed ID: 11080807
[TBL] [Abstract][Full Text] [Related]
28. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.
Igakura T; Stinchcombe JC; Goon PK; Taylor GP; Weber JN; Griffiths GM; Tanaka Y; Osame M; Bangham CR
Science; 2003 Mar; 299(5613):1713-6. PubMed ID: 12589003
[TBL] [Abstract][Full Text] [Related]
29. Dendritic Cells Promote the Spread of Human T-Cell Leukemia Virus Type 1 via Bidirectional Interactions with CD4
Shimauchi T; Caucheteux S; Finsterbusch K; Turpin J; Blanchet F; Ladell K; Triantafilou K; Czubala M; Tatsuno K; Easter T; Ahmed Z; Bayliss R; Hakobyan S; Price DA; Tokura Y; Piguet V
J Invest Dermatol; 2019 Jan; 139(1):157-166. PubMed ID: 30048652
[TBL] [Abstract][Full Text] [Related]
30. Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis.
Koganti R; Memon A; Shukla D
Semin Thromb Hemost; 2021 Apr; 47(3):283-294. PubMed ID: 33851373
[TBL] [Abstract][Full Text] [Related]
31. APOBEC3G targets human T-cell leukemia virus type 1.
Sasada A; Takaori-Kondo A; Shirakawa K; Kobayashi M; Abudu A; Hishizawa M; Imada K; Tanaka Y; Uchiyama T
Retrovirology; 2005 May; 2():32. PubMed ID: 15943885
[TBL] [Abstract][Full Text] [Related]
32. Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator.
Younis I; Khair L; Dundr M; Lairmore MD; Franchini G; Green PL
J Virol; 2004 Oct; 78(20):11077-83. PubMed ID: 15452228
[TBL] [Abstract][Full Text] [Related]
33. Virological and immunological mechanisms in the pathogenesis of human T-cell leukemia virus type 1.
Satou Y; Matsuoka M
Rev Med Virol; 2013 Sep; 23(5):269-80. PubMed ID: 23606621
[TBL] [Abstract][Full Text] [Related]
34. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
35. Infection of CD4+ T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptor's large extracellular domain.
Jin Q; Agrawal L; VanHorn-Ali Z; Alkhatib G
Virology; 2006 May; 349(1):184-96. PubMed ID: 16519917
[TBL] [Abstract][Full Text] [Related]
36. c-Maf suppresses human T-cell leukemia virus type 1 Tax by competing for CREB-binding protein.
Hieshima K; Nagakubo D; Shigeta A; Tanaka Y; Hoshino H; Tsukasaki K; Yamada Y; Yoshie O
Cancer Sci; 2011 Apr; 102(4):890-4. PubMed ID: 21244576
[TBL] [Abstract][Full Text] [Related]
37. Majority of interferon-gamma-producing CD4+ cells in patients infected with human T cell lymphotrophic virus do not express tax protein.
Mitre E; Thompson RW; Carvalho EM; Nutman TB; Neva FA
J Infect Dis; 2003 Aug; 188(3):428-32. PubMed ID: 12870125
[TBL] [Abstract][Full Text] [Related]
38. Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection.
Kalia M; Chandra V; Rahman SA; Sehgal D; Jameel S
J Virol; 2009 Dec; 83(24):12714-24. PubMed ID: 19812150
[TBL] [Abstract][Full Text] [Related]
39. Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum Conditions.
Fons NR; Kines RC; Thompson CD; Day PM; Lowy DR; Schiller JT
J Virol; 2022 Apr; 96(7):e0185721. PubMed ID: 35285688
[TBL] [Abstract][Full Text] [Related]
40. A tax on luxury: HTLV-I infection of CD4+CD25+ Tregs.
Fujinami RS
J Clin Invest; 2005 May; 115(5):1144-6. PubMed ID: 15864345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
